Solution-state NMR structure and biophysical characterization of zinc-substituted rubredoxin B (Rv3250c) from Mycobacterium tuberculosis by Buchko, Garry W. et al.
structural communications
1148 doi:10.1107/S1744309111008189 Acta Cryst. (2011). F67, 1148–1153
Acta Crystallographica Section F
Structural Biology
and Crystallization
Communications
ISSN 1744-3091
Solution-state NMR structure and biophysical
characterization of zinc-substituted rubredoxin B
(Rv3250c) from Mycobacterium tuberculosis
Garry W. Buchko,
a,b* Stephen N.
Hewitt,
a,c Alberto J. Napuli,
a,c
Wesley C. Van Voorhis
a,c and
Peter J. Myler
a,d,e
aSeattle Structural Genomics Center for
Infectious Disease, http://www.ssgcid.org, USA,
bBiological Sciences Division, Pacific Northwest
National Laboratory, Richland, Washington,
USA,
cDepartment of Medicine, University of
Washington, Seattle, Washington, USA,
dSeattle Biomedical Research Institute, Seattle,
Washington, USA, and
eDepartment of Medical
Education and Biomedical Informatics and
Department of Global Health, University of
Washington, Seattle, Washington, USA
Correspondence e-mail:
garry.buchko@pnnl.gov
Received 10 January 2011
Accepted 3 March 2011
PDB Reference: rubredoxin B, 2kn9.
Owing to the evolution of multi-drug-resistant and extremely drug-resistant
Mycobacterium tuberculosis strains, there is an urgent need to develop new
antituberculosis strategies to prevent TB epidemics in the industrial world.
Among the potential new drug targets are two small nonheme iron-binding
proteins, rubredoxin A (Rv3251c) and rubredoxin B (Rv3250c), which are
believed to play a role in electron-transfer processes. Here, the solution
structure and biophysical properties of one of these two proteins, rubredoxin B
(Mt-RubB), determined in the zinc-substituted form are reported. The zinc-
substituted protein was prepared by expressing Mt-RubB in minimal medium
containing excess zinc acetate. Size-exclusion chromatography and NMR
spectroscopy indicated that Mt-RubB was a monomer in solution. The structure
(PDB entry 2kn9)was generally similar tothose ofother rubredoxins, containing
a three-stranded antiparallel  -sheet ( 2– 1– 3) and a metal tetrahedrally
coordinated to the S atoms of four cysteine residues (Cys9, Cys12, Cys42 and
Cys45). The ﬁrst pair of cysteine residues is at the C-terminal end of the ﬁrst
 -strand and the second pair of cysteine residues is towards the C-terminal end
of the loop between  2 and  3. The structure shows the metal buried deeply
within the protein, an observation that is supported by the inability to remove
the metal with excess EDTA at room temperature. Circular dichroism
spectroscopy shows that this stability extends to high temperature, with
essentially no change being observed in the CD spectrum of Mt-RubB upon
heating to 353 K.
1. Introduction
In 2008, approximately 1.6 million people died from the infectious
disease tuberculosis (TB) and another ten million people became
infected (World Health Organization, 2009). The etiological agent
responsible is Mycobacterium tuberculosis, a Gram-positive tubercle
bacillus that is spread largely via the inhalation of droplet M. tuber-
cuosis nuclei expelled from coughing infected individuals (Kaplan et
al., 2003). Approximately one-third of the world’s human population
are infected with TB (Enarson, 2003), although most cases are in 22
‘high-burden’ nations where the disease is endemic (Russell et al.,
2010). In the Western world effective public health care systems keep
TB under control. Unfortunately, such protection may be fragile
(Russell et al., 2010) owing to the evolution of multi-drug-resistant
and extremely drug-resistant M. tuberculosis strains along with
the emergence of the human immunodeﬁciency virus 1 pandemic
(Mitchison, 2005; Basu et al., 2009). Consequently, it is of prime
importance to develop a new generation of intervention strategies to
treat and control TB (Palomino et al., 2009; Myler et al., 2009).
The current conventional TB treatment strategy employs multiple,
not single, drug regimens [e.g. directly observed treatment and short-
course (DOTS) drug therapy; Dye & Williams, 2010]. This is because
it was observed that the accumulation of spontaneous genetic
mutations in M. tuberculosis from single-drug therapy contributed
signiﬁcantly to the emergence of drug-resistant M. tuberculosis
strains (David, 1971; Mitchison, 2005). To identify new anti-TB drugs,
one current tactic is to focus on better understanding the molecular
biology of the M. tuberculosis gene products, especially with regard tothe interaction of various metabolic pathways in the microenviron-
ment in the host (Russell et al., 2010). Because of their likely role in
electron-transfer processes, rubredoxin proteins are potential targets
to be exploited as drug targets against M. tuberculosis. Structural
information on these rubredoxins from X-ray crystallography or
nuclear magnetic resonance (NMR) spectroscopy will assist rational
structure-based drug design (Van Voorhis et al., 2009) targeting these
proteins.
Rubredoxins are small ( 6 kDa) nonheme proteins that coordi-
nate an Fe atom tetrahedrally between the sulfhydryl groups of four
cysteine residues. In addition to iron, rubredoxin may also bind cobalt
(May & Kuo, 1978), nickel (Kowal et al., 1988) or zinc (Blake et al.,
1992; Dauter et al., 1996) at the metal-binding site. The M. tuber-
culosis genome contains two tandem rubrudoxin genes: Rv3251c
(encoding the 55-residue rubredoxin A) and Rv3250c (encoding the
60-residue rubredoxin B). The gene for rubredoxin B is repressed in
vitro under mildly acidic and hypoxic conditions that mimic the state
of dormant tubercle bacilli in granulomas (Kim et al., 2008) and
phagocytosed mycobacteria (Fisher et al., 2002). Here, we report the
NMR-derived solution structure of rubredoxin B (Mt-RubB) in the
zinc-substituted state and describe some of its biophysical properties.
2. Materials and methods
2.1. Cloning, expression and purification
The Mt-RubB gene (Rv3250c/NP_217767.1) was ampliﬁed using
the genomic DNA of M. tuberculosis H37Rv strain and the oligo-
nucleotide primers 50-GGGTCCTGGTTCGATGGTGAACGACT-
ACAAACTGTTC-30 (forward) and 50-CTTGTTCGTGCTGTTTAT-
TACGAGCGAGCCACCTCCACCA-30 (reverse) (Invitrogen,
Carlsbad, California, USA). The ampliﬁed Mt-RubB gene was
then inserted into the expression vector AVA0421 at the NruI/
PmeI restriction sites, which provided a 21-residue tag
(MAHHHHHHMGTLEAQTQGPGS-) at the N-terminus of the
expressed protein. The recombinant plasmid was transformed into
Escherichia coli BL21 (DE3) cells (Novagen, Madison, Wisconsin,
USA) using a heat-shock method. Uniformly
15N- and
15N-,
13C-
labeled Mt-RubB was obtained by growing the transformed cells
(310 K) in minimal medium (Miller) containing
15NH4Cl (1 mg ml
 1)
and d-[
13C6]glucose (2.0 mg ml
 1) supplemented with zinc acetate
(6.1 mgm l
 1) and the antibiotics chloramphenicol (35 mgm l
 1) and
ampicillin (100 mgm l
 1). Once the cells reached an OD600 of  0.8,
the medium was cooled to 298 K and supplemented with further zinc
acetate (an additional 34.2 mgm l
 1) and protein expression was
induced with isopropyl  -d-1-thiogalactopyranoside (0.026 mgm l
 1).
To prepare iron-substituted Mt-RubB the procedure was identical
except for the omission of zinc acetate and the substitution of FeCl3
(50 mgm l
 1) at the start of the growth. Approximately 5 h later the
cells were harvested by mild centrifugation and frozen at 193 K. After
thawing and resuspension in  35 ml lysis buffer (0.3 M NaCl, 50 mM
sodium phosphate, 10 mM imidazole, pH 8.0) brought to 0.2 mM
phenylmethylsulfonyl ﬂuoride (PMSF), the cells were passed through
a French press (SLM Instruments, Rochester, New York, USA) three
times. The suspension was sonicated for 60 s and then centrifuged at
25 000g for 1 h in a JA-20 rotor (Beckman Instruments, Fullerton,
California, USA) to remove insoluble cell debris. Following ﬁltration
through a 0.45 mm syringe ﬁlter, the supernatant was applied onto an
Ni–NTA afﬁnity column (Qiagen, Valencia, California, USA)
containing  25 ml resin. Using gravity, the column was washed
sequentially with 40 ml buffer (0.3 M NaCl, 50 ml sodium phosphate,
pH 8.0) containing increasing concentrations of imidazole (5, 10, 20,
50 and 250 mM). Mt-RubB eluted mainly in the 250 mM imidazole
wash. The protein was concentrated to  2 ml (Amicon Centriprep-
10) and loaded onto a Superdex 75 HiLoad 16/60 column (GE
Healthcare, Piscataway, New Jersey, USA) at a ﬂow rate of
1.0 ml min
 1 to simultaneously purify the protein and exchange it
into NMR buffer (100 mM NaCl, 20 mM Tris–HCl, 1.0 mM dithio-
threitol, pH 7.1). The band containing Mt-RubB (retention time of
82 min) was collected and the volume was reduced (Amicon
Centriprep-10) to generate NMR samples in the 1–2 mM concen-
tration range (Lowry analysis) that were judged to be >95% pure by
SDS–PAGE.
2.2. Circular dichroism spectroscopy
A calibrated Aviv Model 410 spectropolarimeter (Lakewood, New
Jersey, USA) was used to collect circular dichroism data from an
 0.05 mMM t -RubB sample in NMR buffer. Steady-state wavelength
spectra were recorded on the same sample in a quartz cell of 0.1 cm
path length at 0.5 nm increments between 200 and 260 nm at 298 K.
Steady-state wavelength spectra were recorded in duplicate with a
bandwidth of 1.0 nm and a time constant of 1.0 s and the average was
reported. The average spectra were processed by subtracting a blank
spectrum from the protein spectrum and then automatically line-
smoothing the data using the Aviv software. A thermal denaturation
curve was obtained by recording the ellipticity at 226 nm in 2.0 K
intervals from 283 to 353 K.
2.3. NMR spectroscopy
The NMR data were recorded on 1–2 mM samples at 293 K using
Varian 750- and 600-Inova spectrometers equipped with
1H/
13C/
15N
triple-resonance probes and pulse-ﬁeld gradients. The data were
processed with Felix2007 (Felix NMR Inc., San Diego, California,
USA) and analyzed with Sparky (v. 3.115; Goddard & Kneller, 2008).
Standard 2D
1H–
15N HSQC,
1H–
13C HSQC, HBCBCGCDHD and
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Table 1
Summary of the structural statistics for Mt-RubB.
All statistics are for the 20-structure ensemble deposited in the PDB (entry 2kn9) using
the residues containing the central core (Asp3–Glu56).
Restraints for structure calculations
Total NOEs 892
Intraresidue NOEs 204
Sequential (i, i + 1) NOEs 245
Medium-range (i, i + j;1<j   4) NOEs 157
Long-range (i, i + j; j > 4) NOEs 286
’-angle restraints 37
 -angle restraints 37
Hydrogen-bond restraints 34
Zinc–sulfur restraints 10
Structure calculations
No. of structures calculated 100
No. of structures used in ensemble 20
Structures with restraint violations
Distance restraint violations > 0.05 A ˚ 0
Dihedral restraint violations > 1  1
R.m.s.d. from mean (A ˚ )
Backbone N—C
 —C O atoms 0.39   0.07
All heavy atoms 0.76   0.08
All atoms 0.88   0.08
Ramachandran plot summary using PROCHECK (%)
Most favored regions 87.3
Additionally allowed regions 12.2
Generously favored regions 0.4
Disallowed regions 0.0
Global quality scores†
PROCHECK (all)  2.42 ( 0.61)
PROCHECK (’,  )  2.08 ( 0.41)
MolProbity clash score  1.26 (16.25)
† Z scores; values in parentheses are raw values.HBCBCGCDCHE experiments and 3D HNCACB, CBCA(CO)NH,
HNCO, HCC-TOCSY-NNH and CC-TOCSY-NNH experiments
from the Varian Protein Pack pulse-program suite were used to assign
the
1H,
13C and
15N chemical shifts of the backbone and side-chain
resonances. Chemical shifts were referenced to DSS (DSS = 0 p.p.m.)
using indirect methods (Wishart et al., 1995). Distance restraints for
the structure calculations were obtained from 3D
13C-edited aliphatic
and aromatic NOESY-HSQC experiments and an
15N-edited
NOESY-HSQC experiment using a mixing time of 80 ms. Slowly
exchanging amides were identiﬁed by lyophilizing an
15N-labeled
NMR sample, redissolving it in 99.8% D2O and immediately
collecting
1H–
15N HSQC spectra 10, 20 and 60 min after exchange
(deuterium-exchange experiment). To test the efﬁciency of EDTA in
removing metal bound to Mt-RubB, an  1m M sample of Zn-
substituted
15N-labeled Mt-RubB was treated with a 100-fold excess of
ethylenediaminetetraacetic acid (EDTA) and an
1H–
15N HSQC
spectrum was collected. An overall rotational correlation time,  c,
was estimated for Mt-RubB from backbone amide
15N T1/T1  ratios
(Farrow et al., 1994; Buchko et al., 2008).
2.4. Structure calculations
The majority of the backbone and side-chain
1H,
13C and
15N
chemical shifts for Mt-RubB were assigned using established proto-
cols (Cavanagh et al., 1996) and were deposited with the Biological
Magnetic Resonance Data Bank (BMRB) under accession number
16473. Structure calculations were performed iteratively using
CYANA (v.2.1; Gu ¨ntert, 2004) with the chemical shift assignments
and the peak-picked data from
13C- and
15N-edited NOESY-HSQC
experiments as initial inputs. 37 dihedral angle restraints for both
’ and   were introduced on the basis of the elements of secondary
structure identiﬁed in the early structural ensembles and TALOS
calculations (Cornilescu et al., 1999). Near the end of the iterative
process 34 hydrogen-bond restraints (1.8–2.0 and 2.7–3.0 A ˚ for the
NH—O and N—O distances, respectively) and ten zinc–sulfur
restraints (2.2–2.4 and 3.4–4.5 A ˚ for the Zn—S and S—S distances,
respectively) were introduced into the structure calculations on the
basis of proximity in early structure calculations and the observation
of slowly exchanging amides (Table 1) in the deuterium-exchange
experiment. In the ﬁnal set of 100 calculated structures, the 20 with
the lowest target function were selected and reﬁned with explicit
water (Linge & Nilges, 1999) with CNS (v.1.1) using force constants of
500, 500 and 700 kcal (1 kcal = 4.186 kJ) for the NOE, hydrogen
bonds and dihedral restraints, respectively. For the water-reﬁnement
calculations the upper boundary of the CYANA distance restraints
was increased by 5% and the lower boundary was set to the van der
Waals limit. This water-reﬁned ensemble of 20 structures was
deposited in the Protein Data Bank (PDB) under PDB code 2kn9.
Structural quality was assessed using the Protein Structure Validation
Suite (PSVS; v. 1.3; Bhattacharya et al., 2007) and is included in the
structure-statistics summary provided in Table 1.
Note that the amino-acid sequence of Mt-RubB deposited in the
PDB and BMRB is numbered sequentially, Met1–Ser81, starting with
the 21 non-native residues at the N-terminus. Here, the ﬁrst 21
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Figure 1
(a)T h e
1H–
15N HSQC spectrum (red) of iron-associated Mt-RubB. (b) Assigned
1H–
15N HSQC spectrum (blue) of zinc-associated Mt-RubB collected at 293 K in NMR
buffer (100 mM NaCl, 20 mM Tris–HCl, 1.0 mM DTT, pH 7.1) at a
1H resonance frequency of 600 MHz. The cross-peaks for the 21-residue tag are labeled in magenta and
with an asterisk. The only assigned side-chain –NH2 resonances are indicated by a dashed horizontal line and the exchangeable ring resonances for Trp22 and Trp33 are
identiﬁed with an ‘r’ [Trp40(r) at 10.81 p.p.m. (
1H) and 131.2 p.p.m. (
15N) is not shown]. A photograph of the NMR tube containing the sample for the respective
1H–
15N
HSQC spectrum is shown as an inset.non-native residues are numbered sequentially with an asterisk
(Gly1*–Ser21*) and the ﬁrst native residue, Met22 in the PDB and
BMRB depositions, is labeled Met1. Hence, it is necessary to add 21
to the native residues described here (any residue without an
asterisk) to ﬁnd the corresponding residue in the PDB and BMRB
depositions.
3. Results and discussion
3.1. Solution structure of Mt-RubB
As shown in the inset in Fig. 1(a), the initial sample preparation of
Mt-RubB was reddish in color, suggesting that much of the protein
had incorporated iron in the oxidized state. Such an incorporation of
iron is further corroborated by the
1H–
15N HSQC spectrum for this
sample, as illustrated in Fig. 1(a). While there is good chemical shift
dispersion in both the proton and nitrogen dimensions, features that
are characteristic of a structured protein, the line widths of the amide
cross-peaks in the spectrum are nonhomogenous, a feature that is
characteristic of a bound paramagnetic species such as iron. Binding
is speciﬁc and tight, as the addition of an  100-fold molar excess of
EDTA to an NMR sample failed to change the color of the sample or
the appearance of the
1H–
15N HSQC spectrum (data not shown).
Further indirect evidence that the Mt-RubB sample in Fig. 1(a)
contained iron is that the reddish color disappeared when the protein
was expressed in minimal medium lacking iron (Schweimer et al.,
2000) and enriched in zinc acetate, as shown in the inset in Fig. 1(b).
More importantly, the
1H–
15N HSQC spectrum of this sample
(Fig. 1b) still displayed good chemical shift dispersion in both the
proton and nitrogen dimensions and the line widths of the amide
cross-peaks were now more uniform, suggesting that the same
paramagnetic species was no longer bound to Mt-RubB. Because
NMR structure calculations are simpler if the paramagnetic effects
arising from the iron can be avoided, the structure for Mt-RubB was
determined using data from the zinc-substituted sample. Such a
substitution has previously been shown to have essentially no effect
on the structure relative to that of iron-substituted rubredoxin from
Clostriudium pasterurianum (Dauter et al., 1996).
In either the iron-substituted or zinc-substituted form, the elution
time of Mt-RubB (with the 21-residue tag) on a size-exclusion column
was identical (82 min) and consistent with a monomeric species. Such
a conclusion was also corroborated by an estimated rotational
correlation time for zinc-substituted Mt-RubB at 293 K (5.5   0.2 ns)
that was more consistent with a monomeric 9 kDa species then a
18 kDa dimer (Bhattacharjya et al., 2004). As illustrated in Fig. 1(b),
all of the amide resonances for zinc-substituted Mt-RubB, including
residues Gly10*–Ser21* in the N-terminal tag, were unambiguously
assigned in the
1H–
15N HSQC spectrum. On the basis of the amide
assignments and extensive assignment (94%) of the
13C
  and side-
chain proton and carbon chemical shifts of residues Met1–Ser60
(BMRB ID 16473), an ensemble of structures was calculated for
Mt-RubB (Fig. 2a) that satisﬁed all of the available experimental
NMR data (Table 1): 892 interproton distance restraints (NOE data),
34 hydrogen-bond restraints (deuterium-exchange data), 74 dihedral
angle restraints (TALOS calculations) and ten zinc–sulfur restraints.
Each member of the ﬁnal ensemble of 20 structures agreed well with
the experimental data, with no upper limit violation greater than
0.05 A ˚ and only one torsion-angle violation greater than 1 .T h e
quality of the structure ensemble was also shown to be good using the
PSVS validation software package (Bhattacharya et al., 2007). The
Ramachandran statistics for all of the residues in the ensemble were
overwhelmingly in acceptable space [87.3% of the (’,  ) pairs for Mt-
RubB were found in the most favored regions and 12.2% were within
additionally allowed regions] and all of the structure-quality Z scores
were acceptable (> 5), including the ﬁnal MolProbity clash score of
 1.26.
The ﬁnal set of 20 calculated structures in the ensemble converged
well, as shown mathematically by the statistics in Table 1 and visually
by the superposition of the ordered residues (Asp3–Glu56) in
structural communications
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Figure 2
(a) Backbone superposition of the ensemble of 20 structures calculated for Mt-RubB on the structure closest to the average. The 21-residue N-terminal tag has been removed
for clarity. (b) Cartoon representation of the structure closest to the average structure. The  -strands are colored blue, the 310-helix is colored orange, the zinc ion is colored
magenta and the side-chain and main-chain atoms are shown for the four cysteine residues that coordinate the metal.
Table 2
Comparison of the
13C
  and
13C
  chemical shifts of the cysteine residues in
Mt-RubB with average values for oxidized, reduced and Zn-coordinated cysteine
residues.
Average values are from Kornhaber et al. (2006).
Thiol
13C
  chemical shift
13C
  chemical shift
Average oxidized 57.57   2.46 41.17   3.93
Average reduced 59.25   3.06 28.92   2.11
Zinc-coordinated 59.27   2.12 30.89   1.01
Cys9 59.8   0.2 30.9   0.2
Cys12 58.8   0.2 33.9   0.2
Cys42 57.1   0.2 31.1   0.2
Cys45 59.0   0.2 33.3   0.2Fig. 2(a). The r.m.s.d.s of the structured core of ordered residues
(Asp3–Glu56) in the ensemble from the mean structure are 0.39  
0.07 A ˚ for the backbone atoms (N—C
 —C O) and 0.76   0.8 A ˚ for
all heavy atoms. The N-terminal region containing the polyhistidine
tag, Met1*–Ser21*, was unstructured and disordered and, therefore,
this region was omitted from the superposition shown in Fig. 2(a).
The structure contains one three-stranded antiparallel  -sheet [ 2
(Gly15–Asp17)– 1 (Leu6–Cys9)– 3 (Phe52–Val55)] and a 310-helix
(Ala48–Ser50) N-terminal to  3. The zinc is tetrahedrally coordi-
nated to the S atoms of four cysteine residues (Cys9, Cys12, Cys42
and Cys45) as shown in the single structure cartoon representation in
Fig. 2(b). Such a Cys4-type coordination is corroborated by the
13C
 
chemical shifts for these cysteine residues. As tabulated in Table 2,
the
13C
  chemical shifts for Cys9, Cys12, Cys42 and Cys45 are
between 30.9 and 33.9 p.p.m., values that are in a range that is closer
to the average observed for zinc-coordinated cysteine residues (30.89
  1.01 p.p.m.) than for reduced cysteine residues (28.92   2.11 p.p.m.)
(Kornhaber et al., 2006).
In general, the Cys4-type metal coordination and three-stranded
antiparallel  -sheet ( 2– 1– 3) structure observed for Mt-RubB is
similar to the structures reported for other rubredoxin proteins
associated with various metals (Blake et al., 1992; Sieker et al., 1994;
Dauter et al., 1996; Schweimer et al., 2000). Indeed, a search of the
PDB for structures similar to Mt-RubB (Met1–Ser60) using the
DALI search engine (Holm & Rosenstro ¨m, 2010) generated 77
structures with Z scores greater than 8.4, all of which were annotated
as rubredoxins. Of these 77 DALI-identiﬁed structures, the backbone
r.m.s.d.s from the ordered region of Mt-RubB were 1.0 A ˚ or less for
44 of them. Even though the Mt-RubB structure contains only three
small  -strands and one 310-helix, the small backbone r.m.s.d. of the
core residues (Asp3–Glu56) in the ensemble from the mean structure
(0.48 A ˚ ) suggests that the entire protein adopts a stable conforma-
tion. This has been observed in other rubredoxin structures and has
been attributed to a hydrogen-bonding
network between backbone amides and the
S atoms of the metal-ligated cysteines and a
hydrophobic core. In Mt-RubB there are
four amide proton to cysteine sulfur bond
distances of 3 A ˚ or less (Cys12–Cys12,
Gln10–Cys9, Cys45–Cys45 and Asp44–
Cys42) and Fig.3 illustrates the hydrophobic
core adopted by most of the aromatic
amino-acid side chains (Phe7, Phe14, Tyr16,
Trp22, Trp33, Trp40 and Phe52) and the side
chain of Ile27. It has been suggested that
such a structural organization provides the
environment for the electron-exchange
reactions conducted by rubredoxins (Sieker
et al., 1994).
3.2. Thermostability of Mt-RubB
A consequence of the hydrophobic core
and hydrogen-bonding network about the
Cys4–metal center is that rubredoxins are
very stable proteins (Rader, 2010). Indeed,
rubredoxin from Pyrococcus furiosus,a
hyperthermophilic archaeon, has a melting
temperature of 417 K and is one of the most
thermostable proteins known (LeMaster et
al., 2004). While the limits of the stability of
Mt-RubB were not explored, in general,
rubredoxin B from M. tuberculosis also appears to be a very stable
protein. Fig. 4(a) shows a steady-state wavelength CD spectrum for
Mt-RubB collected at 298 K. The spectrum is highlighted by a double
minimum at 204 and 227 nm. The spectrum is difﬁcult to interpret
because only 14 out of 60 (23%) of the native Mt-RubB residues are
in canonical  -strands or 310-helices and in the full-length protein 21
out of 81 (26%) residues are in the unstructured N-terminal tag.
However, the important observation is in Fig. 4(b), which shows the
change in ellipiticity at 226 nm as a function of temperature between
283 and 353 K. There is essentially no change in the CD signal over
this temperature range, indicating that Mt-RubB is stable to at least
353 K.
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Figure 4
(a) Circular dichroism steady-state wavelength spectrum of Mt-RubB ( 0.05 mM) in NMR buffer collected at
298 K. (b) The CD thermal plot for Mt-RubB obtained by measuring the ellipticity at 226 nm in 2.0 K intervals
between 283 and 353 K.
Figure 3
Cartoon representation of the Mt-RubB structure illustrating the hydrophobic core
of the protein. The  -strands are colored blue, the 310-helix is colored orange, the
zinc ion is colored magenta and the residues of the hydrophobic core (Phe7, Phe14,
Tyr16, Ile27, Trp22, Trp33, Trp40 and Phe52) are colored red.Associated with the thermostability of rubredoxins is a strong
binding afﬁnity to the metal. As mentioned earlier, the incubation of
iron-substituted Mt-RubB (sample shown in Fig. 1a) with 0.1 M
EDTA resulted in no change in the color of the sample or the
1H–
15N
HSQC spectrum. Indeed, incubation of the iron-substituted Mt-RubB
sample in the presence of 0.1 MEDTAfor a prolonged period of time
(>2 months) had no visible effect on the color of the sample or the
1H–
15N HSQC spectrum (data not shown). Part of this protection
from competing chelators is likely to be because the metal is buried
within the protein, as shown for Mt-RubB in Fig. 5. Such a structural
organization of the metal internally near the hydrophobic core would
facilitate electron-transfer processes (Sieker et al., 1994).
4. Conclusions
The solution structure of zinc-substituted Mt-RubB, which is high-
lighted by a Cys4-type metal center and a three-stranded antiparallel
 -sheet rigidly held together by a hydrogen-bonding network and a
hydrophobic core, provides the groundwork for future structure-
based drug design targeting Mt-RubB. Circular dichroism spectro-
scopy shows that Mt-RubB is thermostable to at least 353 K. These
structural and biophysical properties of Mt-RubB are similar to those
observed for other rubredoxins and may be universal features that
are critical for the electron-transport functions of rubredoxins. When
the in vivo electron-transfer partners for Mt-RubB are identiﬁed, the
structure and biophysical properties presented here will assist in the
molecular understanding of the protein’s biological function with its
electron-transfer partner and potentially speed up the conception
and development of new and improved chemotherapeutic agents to
treat and control the spread of tuberculosis.
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of Health and Human Services under Federal Contract No.
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Energy’s Ofﬁce of Biological and Environmental Research (BER)
program located at Paciﬁc Northwest National Laboratory (PNNL).
Battelle operates PNNL for the US Department of Energy.
References
Basu, S., Friedland, G. H., Medlock, J., Andrews, J. R., Shah, N. S., Gandhi,
N. R., Moll, A., Moodley, P., Sturm, A.W. & Galvani,A. P. (2009). Proc. Natl
Acad. Sci. USA, 106, 7672–7677.
Bhattacharjya, S., Xu, P.,Gingras, R.,Shaykhutdinov, R., Wu, C., Whiteway,M.
& Ni, F. (2004). J. Mol. Biol. 344, 1071–1087.
Bhattacharya, A., Tejero, R. & Montelione, G. T. (2007). Proteins, 66, 778–795.
Blake, P. R., Park, J.-B., Zhou, Z. H., Hare, D. R., Adams, M. W. & Summers,
M. F. (1992). Protein Sci. 1, 1508–1521.
Buchko, G. W., Tarasevich, B. J., Bekhazi, J., Snead, M. L. & Shaw, W. J. (2008).
Biochemistry, 47, 13215–13222.
Cavanagh, J., Palmer, A. G., Fairbrother, W. & Skelton, N. (1996). NMR
Spectroscopy: Principles and Practice. San Diego: Academic Press.
Cornilescu, G., Delaglio, F. & Bax, A. (1999). J. Biomol. NMR, 13, 289–302.
Dauter, Z., Wilson, K. S., Sieker, L. C., Moulis, J. M. & Meyer, J. (1996). Proc.
Natl Acad. Sci. USA, 93, 8836–8840.
David, H. L. (1971). Appl. Microbiol. 21, 888–892.
Dye, C. & Williams, B. G. (2010). Science, 328, 856–861.
Enarson, D. A. (2003). Mycobacteria and TB, edited by S. H. E. Kaufmann &
H. Hahn, pp. 1–16. Basel: Kargel.
Farrow, N. A., Muhandiram, R., Singer, A. U., Pascal, S. M., Kay, C. M., Gish,
G., Shoelson, S. E., Pawson, T., Forman-Kay, J. D. & Kay, L. E. (1994).
Biochemistry, 33, 5984–6003.
Fisher, M. A., Plikaytis, B. B. & Shinnick, T. M. (2002). J. Bacteriol. 184, 4025–
4032.
Goddard, T. D. & Kneller, D. G. (2008). Sparky 3. University of California, San
Francisco, USA. http://www.cgl.ucsf.edu/home/sparky/.
Gu ¨ntert, P. (2004). Methods Mol. Biol. 278, 353–378.
Holm, L. & Rosenstro ¨m, P. (2010). Nucleic Acids Res. 38, W545–W549.
Kaplan, G., Post, F. A., Moreira, A. L., Wainwright, H., Kreiswirth, B. N.,
Tanverdi, M., Mathema, B., Ramaswamy, S. V., Walther, G., Steyn, L. M.,
Barry, C. E. & Bekker, L. G. (2003). Infect. Immun. 71, 7099–7108.
Kim, S.-Y., Lee, B.-S., Shin, S. J., Kim, H.-J. & Park, J.-K. (2008). J. Med.
Microbiol. 57, 1473–1480.
Kornhaber, G. J., Snyder, D., Moseley, H. N. & Montelione, G. T. (2006). J.
Biomol. NMR, 34, 259–269.
Kowal, A. T., Zambrano, I. C., Moura, I., Moura, J. J. G., LeGall, J. & Johnson,
M. K. (1988). Inorg. Chem. 27, 1162–1166.
LeMaster, D. M., Tang, J. & Herna ´ndez, G. (2004). Proteins, 57, 118–127.
Linge, J. P. & Nilges, M. (1999). J. Biomol. NMR, 13, 51–59.
May, S. W. & Kuo, J. Y. (1978). Biochemistry, 17, 3333–3338.
Mitchison, D. A. (2005). Eur. Respir. J. 25, 376–379.
Myler, P. J., Stacy, R., Stewart, L. J., Staker, B. L., Van Voorhis, W. C. &
Buchko, G. W. (2009). Infect. Disord. Drug Targets, 9, 493–506.
Palomino, J. C., Ramos, D. F. & da Silva, P. A. (2009). Curr. Med. Chem. 16,
1898–1904.
Rader, A. J. (2010). Phys. Biol. 7, 016002.
Russell, D. G., Barry, C. E. & Flynn, J. L. (2010). Science, 328, 852–856.
Schweimer, K., Hoffmann, S., Wastl, J., Maier, U. G., Ro ¨sch, P. & Sticht, H.
(2000). Protein Sci. 9, 1474–1486.
Sieker, L. C., Stenkamp, R. E. & LeGall, J. (1994). Methods Enzymol. 243,
203–216.
Van Voorhis, W. C., Hol, W. G. J., Myler, P. J. & Stewart, L. J. (2009). PLoS
Comput. Biol. 5, e1000530.
Wishart, D. S., Bigam, C. G., Yao, J., Abildgaard, F., Dyson, H. J., Oldﬁeld, E.,
Markley, J. L. & Sykes, B. D. (1995). J. Biomol. NMR, 6, 135–140.
World Health Organization (2009). Globular Tuberculosis Control: A Short
Update to the 2009 Report. Geneva: World Health Organization.
structural communications
Acta Cryst. (2011). F67, 1148–1153 Buchko et al.   Rubredoxin B 1153
Figure 5
Cartoon representation of the Mt-RubB structure shown in Fig. 2(b) with the
surface represented by a mesh. The  -strands are colored blue, the 310-helix is
colored orange, the zinc ion is colored magenta and the side-chain and main-chain
atoms are shown for the four cysteine residues that coordinate the metal.